Table 1.
| Drug | Rate versus rhythm control | Class of recommendation/level of evidence | FDA category | Dosage | Adverse effects |
|---|---|---|---|---|---|
| Beta-blockers | Rate | Class IIa/C | C | Pregnancy: born small for gestational age, preterm birth, and perinatal mortality [1]. General: bradycardia, hypotension, AV block, bronchospasm | |
| Esmolol | Loading: 0.5 mg/kg over 1 min. Maintenance: 0.06–0.2 mg/k/min | ||||
| Metoprolol | 2.5–5 mg bolus over 2 min, up to 3 doses | ||||
| Propranolol | 0.15 mg/kg | ||||
| Nondihydropyridine calcium channel blockers | Rate | Class IIa/C | C | Pregnancy: increased risk of neonatal seizures, jaundice, and hematologic disorders [2]. General: hypotension, heart failure | |
| Diltiazem | Loading: 0.25 mg/kg/dose over 2 min; may give a second dose at 0.35 mg/kg/dose. Maintenance: 5–15 mg/kg for <24 hr. | ||||
| Verapamil | 0.075–0.15 mg/kg over 2 min | ||||
|
| |||||
| Cardiac glycoside | |||||
| Digoxin | Rate | Class IIb/C | C | Loading: 0.25 mg IV every 2 h, up to 1.5 mg. Maintenance 0.125–0.375 mg daily IV or orally |
Pregnancy: digitalis toxicity may cause fetal demise [3]. General: digitalis toxicity, heart block |
|
| |||||
| Class I C antiarrhythmic agent | |||||
| Flecainide | Rhythm | Class IIb/C | C | General: heart block, ventricular arrhythmias, and heart failure | |
|
| |||||
| Class III antiarrhythmic agent | |||||
| Ibutilide | Rhythm | Class IIb/C | C | 1 mg IV; may repeat dose if no response after 10 min | General: bradycardia, AV block, Torsades |
|
| |||||
| Adjunctive therapies | |||||
| Magnesium | NA | B | 2 g over 15 min | General: respiratory depression | |